DE60309307D1 - Immunoadjuvans - Google Patents

Immunoadjuvans

Info

Publication number
DE60309307D1
DE60309307D1 DE60309307T DE60309307T DE60309307D1 DE 60309307 D1 DE60309307 D1 DE 60309307D1 DE 60309307 T DE60309307 T DE 60309307T DE 60309307 T DE60309307 T DE 60309307T DE 60309307 D1 DE60309307 D1 DE 60309307D1
Authority
DE
Germany
Prior art keywords
soluble protein
tuberculin
precipitates
protein contained
immunoadjuvans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60309307T
Other languages
English (en)
Other versions
DE60309307T2 (de
Inventor
Tadao Ohno
Eiji Uchimura
Lan Huang
Ming Kuang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell- Medicine Inc Tsukuba-Shi Ibaraki Jp
Original Assignee
Cell-Medicine Inc
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell-Medicine Inc, RIKEN Institute of Physical and Chemical Research filed Critical Cell-Medicine Inc
Publication of DE60309307D1 publication Critical patent/DE60309307D1/de
Application granted granted Critical
Publication of DE60309307T2 publication Critical patent/DE60309307T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60309307T 2002-04-18 2003-04-15 Immunoadjuvant Expired - Lifetime DE60309307T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002116132 2002-04-18
JP2002116132A JP3492671B2 (ja) 2002-04-18 2002-04-18 免疫アジュバント
PCT/JP2003/004767 WO2003086455A1 (en) 2002-04-18 2003-04-15 Immunoadjuvant

Publications (2)

Publication Number Publication Date
DE60309307D1 true DE60309307D1 (en) 2006-12-07
DE60309307T2 DE60309307T2 (de) 2007-05-10

Family

ID=29243443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60309307T Expired - Lifetime DE60309307T2 (de) 2002-04-18 2003-04-15 Immunoadjuvant

Country Status (11)

Country Link
US (1) US20060008478A1 (de)
EP (1) EP1495767B1 (de)
JP (1) JP3492671B2 (de)
KR (1) KR100922675B1 (de)
CN (1) CN1305528C (de)
AT (1) ATE343397T1 (de)
AU (1) AU2003235158A1 (de)
CA (1) CA2482929C (de)
DE (1) DE60309307T2 (de)
ES (1) ES2277099T3 (de)
WO (1) WO2003086455A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
JP4238279B2 (ja) * 2006-01-06 2009-03-18 セルメディシン株式会社 免疫アジュバント
WO2007147518A2 (en) 2006-06-20 2007-12-27 Transgene S.A. Use of ppd for the adjuvantation of a nucleic acid vaccine
US8449970B2 (en) 2007-07-23 2013-05-28 3M Innovative Properties Company Antistatic article, method of making the same, and display device having the same
JP2009084292A (ja) * 2008-11-14 2009-04-23 Cell-Medicine Inc 免疫アジュバント
WO2018047797A1 (ja) * 2016-09-06 2018-03-15 セルメディシン株式会社 免疫刺激剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003789A1 (en) * 1993-07-28 1995-02-09 The Johns Hopkins University School Of Medicine Controlled release of pharmaceutically active substances from coacervate microcapsules
WO1995016464A1 (en) * 1993-12-14 1995-06-22 Johns Hopkins University School Of Medicine Controlled release of pharmaceutically active substances for immunotherapy
US6290971B1 (en) * 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
ATE407695T1 (de) * 1999-02-09 2008-09-15 Riken Tumorimpfstoff
JP2005514326A (ja) * 2001-07-10 2005-05-19 コリクサ コーポレイション ミクロスフェア中に封入されたタンパク質およびアジュバントを送達するための組成物および方法
EP1481688A4 (de) * 2002-03-05 2006-04-12 Cell Medicine Inc Verfestigtes immunologisches gewebe-adjuvans

Also Published As

Publication number Publication date
AU2003235158A1 (en) 2003-10-27
WO2003086455A1 (en) 2003-10-23
US20060008478A1 (en) 2006-01-12
KR20050026382A (ko) 2005-03-15
ATE343397T1 (de) 2006-11-15
CA2482929A1 (en) 2003-10-23
KR100922675B1 (ko) 2009-10-19
EP1495767A1 (de) 2005-01-12
ES2277099T3 (es) 2007-07-01
AU2003235158A8 (en) 2003-10-27
CN1646159A (zh) 2005-07-27
EP1495767B1 (de) 2006-10-25
EP1495767A4 (de) 2005-06-01
CN1305528C (zh) 2007-03-21
JP3492671B2 (ja) 2004-02-03
DE60309307T2 (de) 2007-05-10
JP2003306444A (ja) 2003-10-28
CA2482929C (en) 2012-11-20

Similar Documents

Publication Publication Date Title
WO2003009739A3 (en) Apparatus and method for controlling illumination or imager gain in an in-vivo imaging device
WO2003074869A3 (en) Spherical mobility mechanism
AU2002233656A1 (en) Exhaust emission control device
EP1894672A3 (de) Poliervorrichtung
EP1372699A4 (de) Verfahren zur verbesserung der wachstumsleistung eines tieres
AU2003250978A1 (en) Media indexing beacon and capture device
WO2005002379A3 (en) Lighted headwear
EP1967222A3 (de) Mehrzweckmaschine zur Überwachung und Kontrolle von Therapien
EP1384873A4 (de) Motoreinlasssteuervorrichtung
TWI249186B (en) Transfer chamber for cluster system
DE60309307D1 (en) Immunoadjuvans
EP1270403A3 (de) Azimutalpropeller
ATE397425T1 (de) Implantat zur änderung der iris-farbe
EP1455035A3 (de) Abdeckvorrichtung und Mechanismus für Türgriffe
EP1739002A3 (de) Wakeboard-Bindungsvorrichtung und Verfahren zur Herstellung dieser Vorrichtung
WO2006058341A3 (en) System and method for base station heat dissipation using chimneys
WO2003082607A3 (en) Inflatable component connector
USD527448S1 (en) Air deodorizer
USD484963S1 (en) Air freshener device
AU2002365760A1 (en) Finned multi-aperture sheet metal, method of manufacturing the sheet metal, part for exhaust emission control device using the sheet metal, and method of manufacturing the part for exhaust emission control device
USD503468S1 (en) Air freshener device
MXPA03007554A (es) Metodo y dispositivo para la percepcion de un objeto por su forma, su tamano y/o su orientacion.
DE50304817D1 (de) Dichtelement
AU2002244700A1 (en) Method for producing cysteine, cystine and glutathione by fermentation
CA2381756A1 (en) Reciprocator and linear suspension element therefor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CELL- MEDICINE, INC., TSUKUBA-SHI, IBARAKI, JP